Toxicity of hemimethyl-substituted cucurbit[7]uril

Area of Science:

• Supramolecular Chemistry
• Toxicology
• Biomedical Sciences

Background:

• Cucurbit[7]uril (CB[7]) derivatives are explored for biomedical applications.
• Hemimethyl-substituted cucurbit[7]uril (HMeCB[7]) offers superior water solubility compared to CB[7].
• Understanding the toxicity profile of HMeCB[7] is crucial for its pharmaceutical development.

Purpose of the Study:

• To evaluate the developmental toxicity of HMeCB[7] in vivo.
• To assess organ-specific toxicities of HMeCB[7] using zebrafish and in vitro models.
• To compare the toxicity of HMeCB[7] with its parent compound, CB[7].

Main Methods:

• In vivo studies using zebrafish models to assess developmental toxicity.
• In vitro cellular models to evaluate organ-specific toxicities (cardiotoxicity, hepatotoxicity).
• Dose-response analysis of HMeCB[7] at various concentrations.

Main Results:

• HMeCB[7] exhibited negligible developmental toxicity up to 3.2 mM.
• Moderate cardiotoxicity and hepatotoxicity were observed at concentrations of 0.8 mM and above.
• HMeCB[7] demonstrated a generally lower toxicity profile compared to CB[7].

Conclusions:

• HMeCB[7] possesses a favorable toxicity profile, particularly regarding developmental effects.
• The compound shows potential for use as an excipient in pharmaceutical formulations.
• Further research into HMeCB[7] is warranted for medicinal and pharmaceutical applications.